Handelsavisen
prelaunch
Companies ›Healthcare ›WAT.AX
WA
WAT.AX — ASX Advanced Medical Equipment & Technology

Waterco Ltd

A$5,13
Open in Charts → Attach watcher ⌖
— —
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
3,93 %
Op margin
—
ROE
—
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About

Waterco Ltd designs, manufactures, and distributes water heating and cooling systems, primarily serving residential and commercial markets in Australia and New Zealand.

Business. Waterco Ltd (WAT.AX) is an Australian company operating in the Advanced Medical Equipment & Technology industry. The firm is primarily listed on the Australian Securities Exchange (ASX). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

Classification99 %
SectorHealth Care
Industry groupAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
BUY25 analysts
14 buy11 hold0 sell
Avg 12m price target395,61

Analyst recommendations

25 analysts · consensus Buy
Buy14
Hold11
Sell0
12-month price target
395,61
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
25 analysts · indicative
Ownership→
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability
—
not yet wired
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning WAT.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to WAT.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressKevin Hern — Waters Corporation Common Stock2026-02-09 · Republican · OK · Exchange · $1,001 - $15,000
    • CongressLisa McClain — Waters Corporation Common Stock2025-07-22 · Republican · MI · Sale · $1,001 - $15,000
    • CongressLisa McClain — Waters Corporation Common Stock2025-07-16 · Republican · MI · Purchase · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Waterco Ltd (WAT.AX) is an Australian company operating in the Advanced Medical Equipment & Technology industry. The firm is primarily listed on the Australian Securities Exchange (ASX). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

    Classification99 %
    SectorHealth Care
    Industry groupAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    Waterco's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in source documents. The company has no dilutive shares outstanding, with basic and diluted shares outstanding equal at 35,043,739. No liquidity risk is flagged, though the absence of financial data limits the ability to assess short-term obligations or cash flow resilience.

    Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided in the industry configuration. The company reported an EPS of 0.08 AUD in the latest period, but no cohort median or industry benchmark is available for comparison.

    Segment and geographic exposure data are not disclosed in the input, and no revenue concentration metrics are available. The company operates in Australia and New Zealand, but the proportion of revenue derived from each region is unspecified.

    Growth trajectory is not quantified in the outlook, and no numeric deltas are provided for the current or next fiscal year. The company's recent performance is limited to a single EPS data point, with no forward-looking guidance or revenue history available.

    Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. No dilution risk is flagged, as basic and diluted shares are equal. No recent filings or transcripts are available to inform material risk events.

    Recent events are not disclosed in the input data, and no filings or transcripts are available to inform material developments. The company's risk profile is limited to the absence of liquidity data and the lack of disclosed dilutive instruments.

    Key takeaways
    • Waterco operates in the electrical components and equipment industry, focusing on water heating and cooling systems.
    • The company's capital structure shows no dilution risk, with basic and diluted shares outstanding equal.
    • No liquidity risk is flagged, but the absence of balance-sheet data limits the ability to assess short-term financial health.
    • Profitability and growth metrics are not available, and no industry benchmarks are provided for comparison.
    • The company's geographic and segment exposure is not disclosed, limiting visibility into revenue concentration.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2008-08-27
    FY 2008 · Full-year highlights

    Revenue A$244.8M, +82,7% YoY; Operating income +52,7% YoY.

    RevenueA$244.8M+82,7 % YoY
    Operating incomeA$22.2M+52,7 % YoY
    Net incomeA$13.9M+28,2 % YoY
    Free cash flowA$19.8M+60,1 % YoY
    EPS—
    Operating cash flowA$24.5M+119,0 % YoY
    Financials
    Income statement
    RevenueA$244.8M
    Gross profitA$120.3M
    Operating incomeA$22.2M
    Net incomeA$13.9M
    Margins
    Gross margin49.1%
    Operating margin9.1%
    Net margin5.7%
    FCF margin8.1%
    Balance sheet
    Total assetsA$257.8M
    Total liabilitiesA$128.2M
    Total equityA$129.5M
    Cash & equivalents—
    Long-term debtA$80.7M
    Cash flow
    Operating cash flowA$24.5M
    CapEx-A$2.3M
    Free cash flowA$19.8M
    SBC—
    P&L flow · revenue → net income
    Revenue A$244.8MOperating costs A$222.6MTax A$8.3MNet income A$13.9M
    Highlights
    • ▍Revenue A$244.8M, +82,7% YoY
    • ▍Operating income +52,7% YoY
    • ▍Net income +28,2% YoY
    • ▍Free cash flow +60,1% YoY
    • ▍Net margin 5.7%

    Valuation FY

    Market price
    A$5,13
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    —
    Net cashⓘ
    —
    Current ratioⓘ
    —
    Debt / equityⓘ
    —
    ROAⓘ
    —
    ROEⓘ
    —
    Cash conversionⓘ
    —
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Partners1

    Supply chain

    Vendors → WAT ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSWATWATWaterco Ltd1 entityJPMORGAN CHASE & CO.BanksUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowA$330,00
    MeanA$395,61
    MedianA$400,00
    HighA$480,00
    SpotA$5,13
    +7611.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 43 508 sh14 grants14 insiders
    • BADDOUR LINDADirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Ornskov FlemmingDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Batra UditDirector, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 25 283 @ $319,44grant · 2026-02-25
    • Vergnano MarkDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • KUEBLER CHRISTOPHER ADirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Knight HeatherDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Jiang WeiDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Huang Pearl SDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Fraser ClaireDirector · Stock Option (Right to Buy) → Common StockAcquired 877 @ $319,44grant · 2026-02-25
    • FEARON RICHARD HDirector · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Brennan Daniel J.Director · Stock Option (Right to Buy) → Common StockAcquired 57 @ $319,44grant · 2026-02-25
    • Carpio Robert L IIISVP Waters Analytical Sciences · Stock Option (Right to Buy) → Common StockAcquired 4 884 @ $319,44grant · 2026-02-25
    • Bennett JianqingSVP Waters Adv. Diagnostics · Stock Option (Right to Buy) → Common StockAcquired 4 826 @ $319,44grant · 2026-02-25
    • Chaubal AmolSVP & Chief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 7 125 @ $319,44grant · 2026-02-25

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Waterco Ltd Market data — financials · 2026-05-30
    • Waterco Ltd Market data — analyst estimates · 2026-05-30

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,96 %$1M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,69 %$2 059M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,26 %$804M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,24 %$488M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,16 %$304M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,15 %$0M
    • Invesco QQQ TrustFunds · as of 2026-03-310,10 %$646M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,06 %$90M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,05 %$211M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,05 %$243M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,05 %$785M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,05 %$207M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,05 %$242M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,04 %$1 299M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,04 %$2 837M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,04 %$310M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,04 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,04 %$1 640M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,04 %$70M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,04 %$230M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,03 %$191M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,03 %$68M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,03 %$158M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,02 %$44M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,02 %$79M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,02 %$168M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,02 %$364M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,02 %$76M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,01 %$62M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,01 %$34M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,01 %$15M
    • FMR LLCInstitutional Investor · as of 2026-03-310,01 %$150M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$15M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,01 %$12M

    Leadership

    • Udit BatraPresident, Chief Executive Officer, Director

    Insider activity

    Net buying2 buys · 0 sellsnet $451K14 insiders · last 365d
    • Jiang WeiDirector · Common StockOther 67 · 2026-06-30
    • Knight HeatherDirector · Common StockOther 63 · 2026-06-30
    • Carpio Robert L IIISVP Waters Analytical Sciences · Common StockOther 189 @ $369,18$70K · 2026-06-24
    • Chaubal AmolSVP & Chief Financial Officer · Common StockOther 239 @ $352,21$84K · 2026-05-12
    • Bennett JianqingSVP Waters Adv. Diagnostics · Common StockOther 302 @ $304,09$92K · 2026-04-06
    • Jiang WeiDirector · Common StockOther 64 · 2026-03-31
    • Knight HeatherDirector · Common StockOther 68 · 2026-03-31
    • Jiang WeiDirector · Common StockBought 500 @ $289,46$145K · 2026-03-16
    • FEARON RICHARD HDirector · Common StockBought 1 000 @ $306,34$306K · 2026-03-06
    • Chaubal AmolSVP & Chief Financial Officer · Common StockOther 709 @ $307,23$218K · 2026-03-02
    • Batra UditDirector, President and CEO · Common StockOther 3 417 @ $307,23$1,0M · 2026-03-02
    • Bennett JianqingSVP Waters Adv. Diagnostics · Common StockOther 410 @ $307,23$126K · 2026-03-02
    • Ornskov FlemmingDirector · Common StockOther 336 · 2026-02-25
    • BADDOUR LINDADirector · Common StockOther 23 · 2026-02-25
    • Brennan Daniel J.Director · Common StockOther 23 · 2026-02-25
    • FEARON RICHARD HDirector · Common StockOther 23 · 2026-02-25
    • Fraser ClaireDirector · Common StockOther 358 · 2026-02-25
    • Huang Pearl SDirector · Common StockOther 23 · 2026-02-25
    • Jiang WeiDirector · Common StockOther 23 · 2026-02-25
    • Knight HeatherDirector · Common StockOther 23 · 2026-02-25
    • Chaubal AmolSVP & Chief Financial Officer · Common StockOther 1 455 · 2026-02-25
    • Vergnano MarkDirector · Common StockOther 23 · 2026-02-25
    • Batra UditDirector, President and CEO · Common StockOther 5 165 · 2026-02-25
    • Carpio Robert L IIISVP Waters Analytical Sciences · Common StockOther 997 · 2026-02-25
    • Bennett JianqingSVP Waters Adv. Diagnostics · Common StockOther 986 · 2026-02-25

    Short positioning

    3.7Mshares short-1.1% vs prior
    5.32days to cover
    46.6%short of daily vol
    5.4Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    WAT.AXCanonical
    ASX · AUD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown
    Relationship graph
    WATJPM.NAdvanced Medic
    This companySectorPartners

    Evidence & claims

    From filings & derived data
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 0.5%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 0.8%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -7.7%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 11.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 40.1%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 6.9%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 0.5%Derived (calculated)
    • Net margin (FY 2025-12-31): 20.3%Derived (calculated)
    • Return on equity (FY 2025-12-31): 25.1%Derived (calculated)
    • Return on assets (FY 2025-12-31): 12.7%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.73xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.98xDerived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -14.4%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 80.7%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -13.5%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 7.4%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -2.9%Derived (calculated)
    • Shareholders' equity (annual): USD 2.56BSEC XBRL filing
    • Shares outstanding (annual): 59.55MSEC XBRL filing
    • Current assets (annual): USD 2.15BSEC XBRL filing
    • Current liabilities (annual): USD 1.24BSEC XBRL filing
    • Total liabilities (annual): USD 2.52BSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 11SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30INSIDERJiang Wei transacted 67 sh — Director
    2026-06-30INSIDERKnight Heather transacted 63 sh — Director
    2026-06-24 00:00 UTCINSIDER1 insider transaction — 2026-06
    2026-06-24 00:00 UTCINSIDER1 insider transaction — 2026-06
    2026-06-24INSIDERCarpio Robert L III transacted 189 sh — SVP Waters Analytical Sciences ~$70k
    2026-05-22FILING8-K filing →
    2026-05-12 00:00 UTCINSIDER1 insider transaction — 2026-05
    2026-05-12 00:00 UTCINSIDER1 insider transaction — 2026-05
    2026-05-12FILING10-Q filing →
    2026-05-12INSIDERChaubal Amol transacted 239 sh — SVP & Chief Financial Officer ~$84k
    2026-05-05FILING8-K filing →
    2026-05-01 07:17 UTCFILINGRegulatory filing →
    2026-04-09FILINGDEF 14A filing →
    2026-04-06 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-06 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-06INSIDERBennett Jianqing transacted 302 sh — SVP Waters Adv. Diagnostics ~$92k
    2026-03-31 00:00 UTCINSIDER7 insider transactions — 2026-03 · net sell $943k
    2026-03-31 00:00 UTCINSIDER7 insider transactions — 2026-03 · net sell $943k
    2026-03-31INSIDERJiang Wei transacted 64 sh — Director
    2026-03-31INSIDERKnight Heather transacted 68 sh — Director
    2026-03-23FILING8-K filing →
    2026-03-19FILING424B2 filing →
    2026-03-16FILING424B2 filing →
    2026-03-16FILING8-K filing →
    2026-03-16INSIDERJiang Wei bought 500 sh — Director ~$145k
    2026-03-06INSIDERFEARON RICHARD H bought 1.0k sh — Director ~$306k
    2026-03-02INSIDERChaubal Amol transacted 709 sh — SVP & Chief Financial Officer ~$218k
    2026-03-02INSIDERBatra Udit transacted 3.4k sh — Director, President and CEO ~$1.05M
    2026-03-02INSIDERBennett Jianqing transacted 410 sh — SVP Waters Adv. Diagnostics ~$126k
    2026-03-01CONGRESSKevin Hern (house) exchange shares → $1,001 - $15,000
    2026-02-25INSIDEROrnskov Flemming transacted 336 sh — Director
    2026-02-25INSIDERBADDOUR LINDA transacted 23 sh — Director
    2026-02-25INSIDERBrennan Daniel J. transacted 23 sh — Director
    2026-02-25INSIDERFEARON RICHARD H transacted 23 sh — Director
    2026-02-25INSIDERFraser Claire transacted 358 sh — Director
    2026-02-25INSIDERHuang Pearl S transacted 23 sh — Director
    2026-02-25INSIDERJiang Wei transacted 23 sh — Director
    2026-02-25INSIDERKnight Heather transacted 23 sh — Director
    2026-02-25INSIDERChaubal Amol transacted 1.5k sh — SVP & Chief Financial Officer
    Showing the 40 most recent of 68 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage